Viral reservoirs and HIV-specific immunity
- PMID: 19372799
- DOI: 10.1097/01.COH.0000203831.78479.05
Viral reservoirs and HIV-specific immunity
Abstract
Purpose of review: HIV-1 infection is complicated by the presence of latently infected CD4 T cells as well as several anatomical reservoirs that present a barrier to eradication by current antiretroviral therapy. The early establishment of these reservoirs also presents a challenge to the development of preventive vaccines. This review will outline how HIV-1 evades the immune system and establishes latent infection, and will look at reasons why latently infected cells are not eradicated by the immune system. The HIV-specific immune responses in anatomical sanctuaries will be discussed.
Recent findings: HIV-specific immune responses have been studied in several anatomical reservoirs including the gut-associated lymphatic tissue that appears to be a major site of viral replication during primary infection.
Summary: HIV-1 evades the immune system during primary infection. Anatomical sanctuaries are seeded in primary infection, and extensive replication occurs at these sites before the development of HIV-specific CD8 T-cell responses. These responses are not capable of clearing infection.
Similar articles
-
Animal models of HIV-1 latency and persistence.Curr Opin HIV AIDS. 2006 Mar;1(2):103-7. doi: 10.1097/01.COH.0000203833.16597.e3. Curr Opin HIV AIDS. 2006. PMID: 19372792
-
HIV vaccines: can mucosal CD4 T cells be protected?Curr Opin HIV AIDS. 2006 Jul;1(4):272-6. doi: 10.1097/01.COH.0000232341.77790.33. Curr Opin HIV AIDS. 2006. PMID: 19372821
-
Treatment of acute HIV-1 infection: are we getting there?Curr Opin HIV AIDS. 2008 Jan;3(1):67-74. doi: 10.1097/COH.0b013e3282f31d4b. Curr Opin HIV AIDS. 2008. PMID: 19372946
-
Treatment interruption to boost specific HIV immunity in acute infection.Curr Opin HIV AIDS. 2007 Jan;2(1):21-5. doi: 10.1097/COH.0b013e3280119275. Curr Opin HIV AIDS. 2007. PMID: 19372861
-
Role of the gastrointestinal tract in establishing infection in primates and humans.Curr Opin HIV AIDS. 2008 Jan;3(1):22-7. doi: 10.1097/COH.0b013e3282f331b0. Curr Opin HIV AIDS. 2008. PMID: 19372940
Cited by
-
HIV-1 neuroimmunity in the era of antiretroviral therapy.Neurobiol Dis. 2010 Mar;37(3):542-8. doi: 10.1016/j.nbd.2009.12.015. Epub 2010 Jan 4. Neurobiol Dis. 2010. PMID: 20044002 Free PMC article. Review.
-
Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders.Genome Med. 2010 Mar 30;2(3):22. doi: 10.1186/gm143. Genome Med. 2010. PMID: 20353544 Free PMC article.
LinkOut - more resources
Full Text Sources
Research Materials